Zobrazeno 1 - 10
of 25
pro vyhledávání: '"M A, García Marcos"'
Autor:
M C López-Berges, M A García-Marcos, Marcos González, Alberto Orfao, Julia Almeida, Guillermo Martín-Núñez, M. Barbón, David Gonzalez, Ana Balanzategui, J. Fernández-Calvo, Teresa Vallespi, Jesus-Maria Hernandez, Alejandro Martín, Jesús F. San Miguel, Maria-Luz Sanchez, Josep F. Nomdedeu, Pilar de la Fuente
Publikováno v:
Blood. 102:2994-3002
Leukemic B-chronic lymphoproliferative disorders (B-CLPDs) are generally believed to derive from a monoclonal B cell; biclonality has only occasionally been reported. In this study, we have explored the incidence of B-CLPD cases with 2 or more B-cell
Autor:
Luis-Ignacio Sanchez-Abarca, J L Arroyo, C Avila‐Zarza, M A García-Marcos, Alberto Orfao, J F San Miguel, Pablo Menendez, María Tabernero, Aurelio López
Publikováno v:
Transfusion. 41:1212-1216
BACKGROUND: Almost all automated hematology cell analyzers use methods based on either the impedance (PLTi) or the optical (PLTo) properties of the cells for performing platelet counts. To improve the accuracy of platelet counts in peripheral blood (
Autor:
María Consuelo del Cañizo, J Hernández, J M Hernández, Marcos González, Juan Luis García, M A García-Marcos, M B González, J F San Miguel, Norma C. Gutiérrez
Publikováno v:
Leukemia. 15:840-845
To analyze the genomic differences between multiple myeloma (MM) and plasma cell leukemia (PCL), a total of 30 cases were studied by comparative genomic hybridization (CGH). In five cases with a low proportion of plasma cells (PC) in bone marrow, an
Autor:
J L Arroyo, M. D. Caballero, M A García-Marcos, J F San Miguel, M.C. del Cañizo, A Izarra, M. E. Fernández, Norma C. Gutiérrez, Purificación Vicente Galindo, R. Villarroel
Publikováno v:
British Journal of Haematology. 111:987-989
Autor:
Carlos E. Pedreira, María Tabernero, Elaine Sobral da Costa, A. Orfao, M.E. Arroyo, Julia Almeida, M A García-Marcos
Publikováno v:
Leukemia. 20(7)
Currently, multiparameter flow cytometry immunophenotyping is the selected method for the differential diagnostic screening between reactive lymphocytosis and neoplastic B-cell chronic lymphoproliferative disorders (B-CLPD). Despite this, current mul
Autor:
J F San Miguel, A Corrales, M C López-Berges, M J Calmuntia, A. Orfao, Belén Vidriales, Menendez Sanchez, Moro Mj, Julia Almeida, M A García-Marcos
Publikováno v:
Leukemia. 16(8)
Multiparameter immunophenotypic analysis of neoplastic cells has proven to be of great help for the investigation of minimal residual disease in acute leukemias; however, its utility has not been systematically explored in B cell chronic lymphoprolif
Autor:
J, Ciudad, J F, San Miguel, M C, López-Berges, M A, García Marcos, M, González, L, Vázquez, M C, del Cañizo, A, López, J J, Van Dongen, A, Orfao
Publikováno v:
British journal of haematology. 104(4)
Immunophenotypic investigation of minimal residual disease (MRD) has traditionally been based on the investigation of phenotypic aberrants at diagnosis to be used later as a target for MRD detection. This approach has several shortcomings (it is only
Autor:
M C, del Cañizo, A, Brufau, J, Almeida, J, Galende, M A, García Marcos, A, Mota, R, García, J, Fernández Calvo, F, Ramos, P, Fisac, A, Orfao, J F, San Miguel
Publikováno v:
British journal of haematology. 103(1)
The in vitro growth characteristics of a large series of acute myeloid leukaemia (AML) patients and their relationship with other clinical and biological disease characteristics were analysed. Patients with AML were studied, 181 with de novo AML and
Autor:
C, Vallejo, M A, García-Marcos, M C, Del Cañizo, A, Orfao, J, Almeida, L, Escribano, J F, San Miguel, A, Ríos
Publikováno v:
Medicina clinica. 109(9)
Syndrome of abnormal chromatin clumping in leucocytes syndrome (ACCLS) is an uncommon entity which shares clinical and biological features with the myelodysplastic (MDS) and chronic myeloproliferative syndrome. In fact, as some authors consider ACCLS
Autor:
J F, San Miguel, A, Martínez, A, Macedo, M B, Vidriales, C, López-Berges, M, González, D, Caballero, M A, García-Marcos, F, Ramos, J, Fernández-Calvo, M J, Calmuntia, J, Diaz-Mediavilla, A, Orfao
Publikováno v:
Blood. 90(6)
A high complete remission rate is currently achieved in patients with acute myeloid leukemia (AML). However, many patients eventually relapse due to the persistence of low numbers of residual leukemic cells that are undetectable by conventional cytom